We are proud to share a major milestone in the DO-IT trial: the enrollment of patient 200, reached during ESOC—a fantastic achievement and a testament to the collective effort across all sites.
A special recognition goes to the outstanding teams in Karlsbad and Ludwigshafen, who enrolled patients 199 and 200. Our sincere thanks to Prof. Dr. Sibu Mundi and Simon Nagel and their teams for their dedication. As a small token of appreciation, we shared gifts to acknowledge their continued commitment and excellent work.
We would also like to highlight the successful investigators’ meeting held during ESOC on 07.05. It was a pleasure to connect with so many of you—both in person and online. Thank you to everyone who participated and contributed to the productive discussions.
A heartfelt thank you as well to our national coordinators @David Seiffge, @Jan Purrucker, Carlos Molina, Robin Lemmens, Jonathan Coutinho, David Werring, @Christopher Price, Espen Saxhaug Kristoffersen, @Daniel Strbian, Diana Aguiar de Sousa, MD, PhD, @Thomas Gattringer, @Guillaume Turc, @Bruce Campbell, Luciano A. Sposato, MD, MBA, FRCPC, Tsivgoulis Georgios, all participating PIs and site teams, and—most importantly—our patients, who make this progress possible.
Finally, special recognition goes to our top recruiting PIs Jonathan Coutinho, Mira Katan, Gerrit M. Große, Annerose Mengel, Davide Strambo, Prof. Dr. Sibu Mundi, @Jan Purrucker, @Pasquale Scoppettuolo, Robin Lemmens, @Jürgen Bardutzky for their exceptional efforts and contributions to the study’s momentum.
Let’s keep up the great work and continue building this success together 🚀
💉 Small Steps. Big Impact. DO-IT!
